FR2636948B1 - N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant - Google Patents
N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenantInfo
- Publication number
- FR2636948B1 FR2636948B1 FR898912527A FR8912527A FR2636948B1 FR 2636948 B1 FR2636948 B1 FR 2636948B1 FR 898912527 A FR898912527 A FR 898912527A FR 8912527 A FR8912527 A FR 8912527A FR 2636948 B1 FR2636948 B1 FR 2636948B1
- Authority
- FR
- France
- Prior art keywords
- piperidylmethyl
- benzamides
- antiarrhythmic
- substituted
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/248,814 US4952574A (en) | 1988-09-26 | 1988-09-26 | Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2636948A1 FR2636948A1 (fr) | 1990-03-30 |
FR2636948B1 true FR2636948B1 (fr) | 1994-09-30 |
Family
ID=22940797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR898912527A Expired - Fee Related FR2636948B1 (fr) | 1988-09-26 | 1989-09-25 | N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant |
Country Status (3)
Country | Link |
---|---|
US (1) | US4952574A (fr) |
DE (1) | DE3931954A1 (fr) |
FR (1) | FR2636948B1 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6316627B1 (en) * | 1997-04-21 | 2001-11-13 | Fine Tech Ltd. | Process for the preparation of flecainide |
DE19982965B3 (de) * | 1998-12-25 | 2012-08-30 | Jnc Corporation | Flüssigkristalline Verbindung mit einem negativen Wert der dielektrischen Anisotropie |
DE10025700A1 (de) * | 2000-05-26 | 2001-11-29 | Merck Patent Gmbh | Verfahren zur Herstellung von trifluorethoxysubstituierten Benzoesäuren |
US20040220409A1 (en) * | 2001-02-20 | 2004-11-04 | Mcdaniel William C | Flecainide synthesis |
MXPA05008088A (es) * | 2003-02-24 | 2005-09-21 | Mallinckrodt Inc | Proceso mejorado para preparar benzhidril tioacetamida. |
WO2007054785A1 (fr) * | 2005-11-08 | 2007-05-18 | Atheris Laboratories | Peptides de type mu-conotoxine et leur emploi en tant qu'anesthésique local |
AP2014007805A0 (en) | 2011-12-28 | 2014-07-31 | Cytokinetics Inc The Regents Of The University Of California | Substituted benzaldehyde compounds and methods fortheir use in increasing tissue oxygenation |
US9012450B2 (en) | 2011-12-28 | 2015-04-21 | Global Blood Therapeutics, Inc. | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
MX2015011769A (es) | 2013-03-15 | 2016-06-02 | Global Blood Therapeutics Inc | Compuestos y sus usos para modular la hemoglobina. |
EP2970308B1 (fr) | 2013-03-15 | 2021-07-14 | Global Blood Therapeutics, Inc. | Composés et leurs utilisations pour la modulation de l'hémoglobine |
US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
US10100043B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
SG10201802911RA (en) | 2013-03-15 | 2018-05-30 | Global Blood Therapeutics Inc | Compounds and uses thereof for the modulation of hemoglobin |
US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
PT3102208T (pt) | 2014-02-07 | 2021-04-05 | Global Blood Therapeutics Inc | Polimorfos cristalinos da base livre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3 il)metoxi)benzaldeído |
MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
BR112018011272A2 (pt) | 2015-12-04 | 2018-11-21 | Global Blood Therapeutics Inc | regimes de dosagem para 2-hidróxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3-il)metóxi)benzaldeído |
TWI752307B (zh) | 2016-05-12 | 2022-01-11 | 美商全球血液治療公司 | 新穎化合物及製造化合物之方法 |
TWI778983B (zh) | 2016-10-12 | 2022-10-01 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
EP3860975B1 (fr) | 2018-10-01 | 2023-10-18 | Global Blood Therapeutics, Inc. | Modulateurs de l'hémoglobine pour le traitement de la drépanocytose |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3342826A (en) * | 1964-01-13 | 1967-09-19 | Ile De France | Heterocyclic aminoalkyl benzamides |
US4013670A (en) * | 1974-04-01 | 1977-03-22 | Riker Laboratories, Inc. | Derivatives of pyrrolidine and piperidine |
US3900481A (en) * | 1974-04-01 | 1975-08-19 | Riker Laboratories Inc | Derivatives of pyrrolidine and piperidine |
US4005209A (en) * | 1974-04-01 | 1977-01-25 | Riker Laboratories, Inc. | Antiarrhythmic method utilizing fluoroalkoxy-N-piperidyl and pyridyl benzamides |
US4097481A (en) * | 1976-11-08 | 1978-06-27 | Riker Laboratories, Inc. | Tertiary amide derivatives of pyrrolidine and piperidine |
US4071524A (en) * | 1976-11-08 | 1978-01-31 | Riker Laboratories, Inc. | Derivatives of urea |
US4650873A (en) * | 1979-03-19 | 1987-03-17 | Riker Laboratories | Process for the preparation of a derivative of piperidine |
US4452983A (en) * | 1981-06-08 | 1984-06-05 | Riker Laboratories, Inc. | Phenolic derivative |
US4339587A (en) * | 1981-06-08 | 1982-07-13 | Riker Laboratories, Inc. | 5-Benzyloxy or 5-hydroxy-2-(2,2,2-trifluoroethoxy)-N-(2-pyridylmethyl)benzamide |
IT1171707B (it) * | 1983-09-30 | 1987-06-10 | Babcock Samifi Spa | Dispositivo per il raffreddamento dell'olio in una unita' di compressione e, particolarmente, di compressione a vite |
US4599434A (en) * | 1983-11-15 | 1986-07-08 | Riker Laboratories, Inc. | Cyclopentanone derivatives |
US4656285A (en) * | 1983-11-15 | 1987-04-07 | Riker Laboratories, Inc. | Compound 2-acetamidomethyl-6-methoxy-pyridine |
-
1988
- 1988-09-26 US US07/248,814 patent/US4952574A/en not_active Expired - Fee Related
-
1989
- 1989-09-25 DE DE3931954A patent/DE3931954A1/de not_active Withdrawn
- 1989-09-25 FR FR898912527A patent/FR2636948B1/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4952574A (en) | 1990-08-28 |
DE3931954A1 (de) | 1990-03-29 |
FR2636948A1 (fr) | 1990-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2636948B1 (fr) | N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant | |
FR2586562B1 (fr) | Composition pharmaceutique contenant de l'a-methylhistamine | |
FR2604357B1 (fr) | Composition pharmaceutique et cosmetique anti-acneique | |
FR2626002B1 (fr) | Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant | |
PT84737B (pt) | Processo para a preparacao de derivados de n-(2'-aminofenil)-benzamida e de composicoes farmaceuticas contendo-os | |
DK330287D0 (da) | Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme | |
NZ222977A (en) | Aminotetralins and pharmaceutical compositions; 8-substituted-2-aminotetralins and pharmaceutical compositions thereof | |
FR2582513B1 (fr) | Compositions pharmaceutiques contenant de l'alfuzosine | |
PH24749A (en) | Piperidine compounds, pharmaceutical composition and method of use thereof | |
FR2645152B1 (fr) | 3h-pteridinones-4, procedes de preparation et medicaments les contenant | |
FR2601875B1 (fr) | Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol | |
FR2596651B1 (fr) | Nouveaux liposomes a base de phosphatidylinositolmannosides, et compositions pharmaceutiques les contenant | |
BE880065A (fr) | Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant | |
IL78939A0 (en) | N-substituted arylalkyl-and arylalkylene-aminoheterocyclics and pharmaceutical compositions containing them | |
PT87470A (pt) | Process for the preparation of novel substituted benzamides and of pharmaceutical compositions containing the same | |
BE876042A (fr) | Nouvelles 4-(quinoleinylaminobenzoyl) piperidines et composition pharmaceutique les contenant | |
FR2626175B1 (fr) | Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant | |
FR2608921B1 (fr) | Composition pharmaceutique contenant de la ranitidine | |
FR2488135B1 (fr) | Composition pharmaceutique a base de propylene-glycol et d'acetaminophene | |
FR2638640B1 (fr) | Solution pharmaceutique | |
FR2636946B1 (fr) | ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant | |
MC1847A1 (fr) | Fragments d'interferons imnuns recombinants,homogenes et composition pharmaceutiques les contenant | |
FR2352790A1 (fr) | Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant | |
FR2598617B1 (fr) | Composition pharmaceutique | |
FR2446819B1 (fr) | Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |